Anhedonia vs. Depression: What's the Difference and Why It Matters
Author:
Blossom Editorial
May 26, 2026
If you feel you’ve lost interest in things you used to enjoy, like hobbies, socializing, food, or activities that once felt rewarding, and wonder whether that is depression or something else, you are asking a question that matters clinically.
The inability to feel joy or pleasure, anhedonia, and depression are closely related, but they are not the same thing, and understanding the difference has real implications for treatment.
Anhedonia is a symptom. Depression is a condition. They interact in important ways, and distinguishing between them can help guide more targeted and effective care.
Key Takeaways
Anhedonia, defined as the reduced ability to feel pleasure or interest, is a symptom rather than a diagnosis. It is one of the two core criteria for major depressive disorder, but it also appears in other conditions, including schizophrenia, bipolar disorder, and PTSD.
You can experience anhedonia without meeting the full criteria for clinical depression, and depression can occur without anhedonia as its dominant feature.
Both respond to treatment. Identifying which symptoms are most prominent helps guide the most effective therapeutic and medication approach.
What is Anhedonia?
Anhedonia comes from Greek roots meaning "without pleasure." It refers to the diminished ability to experience enjoyment from previously pleasurable activities. But anhedonia is more than simply not enjoying things. It involves a broader reduction in motivation, anticipation, and reward responsiveness.
Research published describes anhedonia as involving dysfunction in the brain's dopamine reward system, particularly the circuits that drive motivation and anticipation of reward, not just the experience of pleasure itself.
There are two forms of anhedonia.
Consummatory anhedonia refers to reduced pleasure while actually doing something, such as eating food that used to taste wonderful or spending time with people you love.
Anticipatory anhedonia refers to reduced motivation and excitement in looking forward to something.
Both forms affect quality of life, but anticipatory anhedonia may have a stronger effect on daily functioning because it erodes the drive to initiate any activity.
Anhedonia can range from mild to severe. In milder forms, a person may notice that things feel less enjoyable than they used to. In more severe presentations, virtually nothing produces any emotional response, and activities are carried out purely out of obligation or habit.
What is Depression?
Major depressive disorder (MDD) is a clinical diagnosis defined by specific criteria in the DSM-5. To receive a diagnosis of MDD, a person must experience five or more symptoms during the same two-week period, with at least one of those symptoms being either depressed mood or anhedonia. Depression is one of the most common mental disorders in the United States, affecting millions of adults each year and ranking among the leading causes of disability worldwide.
Depression is a multi-symptom syndrome that can involve persistent sadness, anhedonia, changes in sleep and appetite, fatigue, difficulty concentrating, feelings of worthlessness or guilt, and, in severe cases, thoughts of death or suicide. It is a whole-system condition that affects thought, emotion, motivation, and physical function simultaneously.
Depression doesn’t look the same for everyone. Some people feel deeply sad and cry often, while others mostly feel emotionally numb, disconnected, or lose interest in things they used to enjoy without being visibly sad. This kind of depression is often driven by anhedonia, the inability to feel pleasure, and can be associated with high-functioning depression or persistent depressive disorder (dysthmia).
How Anhedonia and Depression Differ
The clearest distinction is structural. Anhedonia is one symptom within a broader condition. Depression is the condition itself. Think of depression as a storm system: anhedonia may be the most visible part of it for some people, but the storm involves many other elements as well.
Anhedonia doesn’t only happen with depression. It can also show up in conditions like schizophrenia, bipolar disorder during depressive episodes, PTSD, and substance use disorders. Some people may also experience it during burnout, chronic fatigue, or certain neurological conditions. In these situations, improving anhedonia usually means treating the underlying condition that’s causing it.
Treatments Available
Both anhedonia and depression typically respond to treatment, though anhedonia can sometimes be the more treatment-resistant element of a depressive episode.
Antidepressant Medications
Selective serotonin reuptake inhibitors (SSRIs) and serotonin and norepinephrine reuptake inhibitors (SNRIs) are first-line treatments for depression and can help with anhedonia, though research suggests they may be more consistently effective for mood, sleep, anxiety, and cognitive symptoms than for the reward-deficit aspects of anhedonia specifically.
Bupropion (Wellbutrin), which acts on dopamine and norepinephrine rather than serotonin, may be more targeted for anhedonia given the role of dopamine in reward processing.
A systematic review from 2019 showed newer antidepressants such as vortioxetine, agomelatine, and ketamine to be more promising in the treatment of anhedonia in MDD.
Psychotherapy
Behavioral activation is a therapeutic approach which may be useful for anhedonia. It involves gradually and systematically reintroducing rewarding activities, even when motivation is low, to help restart the brain's reward system through repeated positive experience. Cognitive behavioral therapy addresses the thought patterns that reinforce avoidance and emotional numbness. Both approaches have strong evidence bases for depression.
A pilot, randomized controlled trial from 2023 examined a novel treatment strategy called Adept Depression Therapy (ADepT) by comparing it with CBT for patients with depression and exhibiting anhedonia features. The study showed initial proof of concept for ADepT as an effective treatment with long-term benefits and better cost-effectiveness compared to CBT.
Esketamine
For treatment-resistant cases, esketamine (Spravato), an FDA-approved nasal spray, has shown promising results for rapidly reducing depressive symptoms, including anhedonia. This is particularly relevant when traditional antidepressants have not provided adequate relief.
Anhedonia in Specific Conditions
Understanding where anhedonia appears beyond depression can help people recognize it in themselves, even when they do not fit the typical image of someone who is depressed.
In schizophrenia, anhedonia is one of the so-called negative symptoms, reflecting a deficit in emotional responsiveness and motivation rather than positive symptoms like hallucinations or delusions. Treatment of negative symptoms, including anhedonia, is one of the more challenging aspects of schizophrenia care.
In bipolar disorder, anhedonia tends to emerge during depressive episodes and can be particularly severe. During manic or hypomanic phases, the opposite is often true: pleasure and motivation may be heightened to an unusual degree, creating a sharp contrast when the mood shifts.
In PTSD, emotional numbing and diminished interest in activities are recognized diagnostic criteria and represent the brain's attempt to protect itself from overwhelming emotional experience. Treating the underlying trauma often results in gradual recovery of emotional responsiveness.
When to Seek Help
If you notice a persistent loss of pleasure or interest, even if you do not feel classically sad or depressed, that experience is worth discussing with a professional. Anhedonia significantly affects quality of life and rarely resolves fully on its own when connected to an underlying condition.
If you’re struggling with anhedonia or depression, Blossom Health can help you connect with board-certified psychiatric providers who understand how these symptoms can affect daily life. Through convenient online appointments, the team can provide personalized treatment plans, medication management when appropriate, and ongoing support to help you regain motivation, improve your mood, and start feeling more like yourself again.
Monitoring Progress
One practical challenge with anhedonia is that improvement can be gradual and subtle. Unlike sadness, which is often easy to notice when it lifts, the return of pleasure and motivation can be slow enough to miss. Keeping track of activities that produce even a small positive response and noticing whether that list grows over time is a useful way to monitor progress during treatment.
Medical Disclaimer
This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. If you are experiencing a mental health crisis, contact the 988 Suicide and Crisis Lifeline by calling or texting 988.
Sources
Treadway MT, Zald DH. 2011. Reconsidering anhedonia in depression. Neuroscience and Biobehavioral Reviews. https://pubmed.ncbi.nlm.nih.gov/20603146/
National Institute of Mental Health. Depression. https://www.nimh.nih.gov/health/topics/depression
American Psychiatric Association. DSM-5. https://www.psychiatry.org/psychiatrists/practice/dsm
Serretti A. 2025. Anhedonia: Current and future treatments. PCN Rep. 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC11930767/
Vasiliu O. 2023. Esketamine for treatment‑resistant depression: A review of clinical evidence (Review). Exp Ther Med. https://pmc.ncbi.nlm.nih.gov/articles/PMC9922941/
Cleveland Clinic. Anhedonia. https://my.clevelandclinic.org/health/symptoms/25155-anhedonia
NIMH. Mental Health Medications. https://www.nimh.nih.gov/health/topics/mental-health-medications
Pizzagalli DA. 2014. Depression, stress, and anhedonia. Annual Review of Clinical Psychology. https://pubmed.ncbi.nlm.nih.gov/24471371/
Wu, C., Mu, Q., Gao, W., & Lu, S. (2025). The characteristics of anhedonia in depression: a review from a clinically oriented perspective. Translational psychiatry, 15(1), 90. https://doi.org/10.1038/s41398-025-03310-w
American Psychiatric Association. What Is Depression?. https://www.psychiatry.org/patients-families/depression/what-is-depression
NIMH. Anxiety and Depression. https://www.nimh.nih.gov/health/topics/anxiety-disorders
